News & Updates

Children who are exposed to paternal depression are at increased risk of depression, as shown in a study.

In the treatment of patients with paroxysmal atrial fibrillation (AF), pulse field ablation (PFA) system appears to yield safety and efficacy outcomes that are noninferior to those of conventional thermal ablation, according to data from the ADVENT trial.

Dietary eicosapentaenoic acid/docosahexaenoic acid/docosapentaenoic acid (EPA/DHA/DPA) does not seem to increase the risk of atrial fibrillation (AF) but even shows an inverse association with AF in a nonlinear manner, according to a study.

In a prospective study from China, a novel noninvasive stool DNA methylation assay showed promise for the early detection of multiple gastrointestinal (GI) cancers.

Retinal thinning predicts disability in patients newly diagnosed with relapsing multiple sclerosis (MS), an immune-mediated disease affecting the brain and spinal cord, in a new study presented at EAN 2023.

Treatment with tremelimumab plus durvalumab (STRIDE* regimen) continues to yield overall survival (OS) benefit at 4 years among patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib, according to the updated results of the HIMALAYA trial presented at ESMO WCGIC 2023.

Frailty is associated with greater treatment cost and mortality among hospitalized children with cancer, suggests a US study, noting the need for further research on frailty-based risk stratification, as well as individualized intervention to improve patient outcomes.